BiotechTube

Donepezil 5 mg + Donepezil 10 mg + Donepezil matched placebo

Phase 3Completed
1 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Dementia With Lewy Bodies (DLB)

Conditions

Dementia With Lewy Bodies (DLB)

Trial Timeline

Feb 1, 2011 → Apr 1, 2013

NCT ID
NCT01278407

About Donepezil 5 mg + Donepezil 10 mg + Donepezil matched placebo

Donepezil 5 mg + Donepezil 10 mg + Donepezil matched placebo is a phase 3 stage product being developed by Eisai for Dementia With Lewy Bodies (DLB). The current trial status is completed. This product is registered under clinical trial identifier NCT01278407. Target conditions include Dementia With Lewy Bodies (DLB).

What happened to similar drugs?

9 of 20 similar drugs in Dementia With Lewy Bodies (DLB) were approved

Approved (9) Terminated (1) Active (10)
✅E2020 + PlaceboEisaiApproved
✅donepezil hydrochloride (Aricept)EisaiApproved
✅MecobalaminEisaiApproved
✅Donepezil hydrochloride + Donepezil matching placebo + Donepezil hydrochlorideEisaiApproved
✅Risperdal,reminylJohnson & JohnsonApproved
✅ENA713NovartisApproved
✅Rivastigmine Patch 9.5 cm2NovartisApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01278407Phase 3Completed

Competing Products

20 competing products in Dementia With Lewy Bodies (DLB)

See all competitors
ProductCompanyStageHype Score
[18F]NAV4694Navidea BiopharmaceuticalsPhase 3
26
AL001 + Placebo + Open label - AL001AlectorPhase 3
22
AL001AlectorPhase 2
25
ATH-1017 + PlaceboLeonaBioPhase 2
17
IGC AD1 + PlaceboIGC PharmaPhase 1
19
E2020 + PlaceboEisaiApproved
43
ARICEPTEisaiPhase 3
40
RasagilineEisaiPhase 2
35
Donepezil HydrochlorideEisaiPre-clinical
26
donepezil hclEisaiPhase 3
40
E2020 + E2020EisaiPhase 2
35
donepezil hydrochloride (Aricept)EisaiApproved
43
3 mg Donepezil hydrochloride + 5 mg Donepezil hydrochloride + 10 mg Donepezil hydrochloride + PlaceboEisaiPhase 2
35
E2020 + E2020EisaiPhase 3
40
Irsenontrine + PlaceboEisaiPhase 2
35
E2020EisaiPhase 2
35
MecobalaminEisaiApproved
43
E2020 + PlaceboEisaiPhase 3
40
Donepezil HydrochlorideEisaiPhase 3
40
Donepezil hydrochloride + Donepezil matching placebo + Donepezil hydrochlorideEisaiApproved
43